PRODUCTS
SERVICES
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
2.59
1 yrs 10 m
1%
418.83 Crs
1% on or before 3M, Nil after 3M
Large Growth
9.08
SIP 1000 & Lumpsum 500
BSE HEALTH CARE - TRI
Sorbh Gupta,Bharat Hegde,Siddharth Chaudhary
Investors understand that their principal will be at very high risk